Invention Grant
- Patent Title: Therapeutic agent for hematopoietic tumors
- Patent Title (中): 造血肿瘤治疗剂
-
Application No.: US13085741Application Date: 2011-04-13
-
Publication No.: US08834876B2Publication Date: 2014-09-16
- Inventor: Masaaki Kosaka , Shuji Ozaki , Yuji Wakahara
- Applicant: Masaaki Kosaka , Shuji Ozaki , Yuji Wakahara
- Applicant Address: JP Tokyo
- Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee Address: JP Tokyo
- Agency: Morrison & Foerster LLP
- Priority: JP2001-031492 20010207
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61P35/02 ; A61K38/17 ; A61K38/21 ; G01N33/574 ; C07K16/30 ; C07K14/555 ; A61K39/00

Abstract:
An inducing agent or enhancing agent, for the expression of HM1.24 antigen in hematopoietic tumor cells, comprising interferon α, interferon γ, or the IRF-2 protein as an active ingredient, as well as an antitumor agent for hematopoietic tumors which comprises a combination of said inducing agent or enhancing agent and an antibody against HM1.24.
Public/Granted literature
- US20110223133A1 THERAPEUTIC AGENT FOR HEMATOPOIETIC TUMORS Public/Granted day:2011-09-15
Information query